covid

AMA Update 356: FDA-authorized COVID boosters, plus Pirola variant & reinfection studies with Andrea Garcia, JD, MPH

COVID-19 cases continue to rise, and the FDA authorizes new COVID-19 boosters. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also discusses the latest news about the Eris (EG.5) and Pirola (BA.2.86) variants, the effects of COVID-19 reinfection, and its relationship with Long COVID. Plus, the CDC’s health advisory on RSV. American Medical Association CXO Todd Unger hosts.

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 350: Latest from the CDC on fall COVID variants, new flu guidelines, plus malaria health alert

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the recent uptick in COVID cases and hospitalizations, what we’ve learned about new variants EG.5, or Eris, and the highly mutated BA.2.86, or Pirola, variant. She also reviews changes in this year’s flu vaccine guidelines and just how concerned we need to be about locally acquired malaria in response to a recent CDC Health Alert. American Medical Association CXO Todd Unger hosts.

🦠 Centers for Disease Control and Prevention Risk Assessment Summary for SARS CoV-2 Sublineage BA.2.86: https://www.cdc.gov/respiratory-viruses/whats-new/covid-19-variant.html

💉 Updates to the Advisory Committee on Immunization Practices Flu Vaccine Recommendations for 2023-2024 season: https://www.cdc.gov/flu/season/faq-flu-season-2023-2024.htm

📍Find out where to get a flu shot in your area: https://getmyflushot.org/

📢 #PSA: Getting an annual flu shot is the best way to reduce your risk of getting sick. Preventing the spread of influenza and keeping your vaccinations up-to-date help protect you and your loved ones during the holiday season.

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 344: Geeta Nayyar, MD, MBA, on misinformation, rebuilding patient trust and good healthcare marketing

#AMAupdate welcomes back former SVP and Chief Medical Officer at Salesforce, Geeta Nayyar, MD, MBA. This episode, Dr. Geeta Nayyar discusses how healthcare leaders can use new technologies like AI and existing social media platforms to reach new patients, rebuild trust in the community, stop the spread of medical misinformation, and combat the anti-science movement. American Medical Association CXO Todd Unger hosts.

📖 For more on Dr. Nayyar’s book «Dead Wrong: Diagnosing and Treating Healthcare’s Information Illness», visit: https://www.barnesandnoble.com/w/dead-wrong-geeta-nayyar/1143303950

🔋 AMA efforts to stop physician burnout: https://bit.ly/AMARecoveryPlan_Burnout

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 334: Summer COVID surge, red meat allergy from ticks, and new FDA approved OTC naloxone nasal spray

The CDC sees signs of a late summer COVID wave. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses the rise in cases, whether there is cause for concern and who is most at risk. Plus, the latest news about Alpha-gal syndrome (AGS) cases and the FDA approval of the second over-the-counter naloxone nasal spray, RiVive. American Medical Association CXO Todd Unger hosts.

💻 Access CDC AGS resources and Alpha-gal Syndrome Clinician Training (CME credit), here: https://www.cdc.gov/ticks/alpha-gal/resources/index.html

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 301: Long COVID: New research, common symptoms, long-term effects and treatments with Akiko Iwasaki, PhD

Akiko Iwasaki, PhD, returns to AMA Update to share the latest science behind long COVID, including how many people are still suffering, most common symptoms and what we know about treatments like Paxlovid. She also shares guidance for physicians on diagnosing long COVID, treating post-COVID patients and new research to watch. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 297: FDA approvals, CDC recommendations and WHO COVID announcement with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest news from the World Health Organization, Centers for Disease Control and Prevention, and the Food and Drug Administration’s upcoming Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting this June. Including the U.S. Public Health Emergency (PHE) for COVID-19 ending on May 11, 2023. American Medical Association CXO Todd Unger hosts.

🦠 For more information and to register for «Infection Prevention and Control Post-COVID-19 PHE: A Town Hall with CDC’s Project Firstline» on May 11, visit: https://edhub.ama-assn.org/cdc-project-firstline/video-player/18780695

Read More

AMA Update 281: Medicaid eligibility, COVID cases in the U.S., C. auris & Marburg fever with Andrea Garcia, JD, MPH

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses important changes in Medicaid coverage following the Consolidated Appropriations Act of 2023, coronavirus statistics and reporting slowdowns—as well as the latest on Candida auris and the Marburg fever outbreak. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 277: Candida auris, Marburg virus and latest FDA COVID booster authorizations with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest news physicians need to know, including: tracking the Marburg virus disease (MVD) outbreak, Candida auris symptoms, how sleep can impact vaccine effectiveness, and the FDA’s latest authorization that certain children six months through four years old are now eligible to receive a single booster dose of Pfizer-BioNTech’s updated bivalent shot. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 275: Candida auris, Paxlovid and maternal mortality rates with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest news physicians need to know, including: new updates from the FDA on Paxlovid, data from a recently released study on maternal mortality rates increasing in the U.S., and the CDC’s warning on the spread of a deadly fungus, Candida auris. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 272: Long COVID: what we do and don’t know after 3 years of the pandemic with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, summarizes what we’ve learned—and what unknowns still linger as the COVID pandemic crosses the three-year mark. American Medical Association CXO Todd Unger hosts.

Read More